| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee2b4cf5180521e069e04d91bced4ff1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 |
| filingDate |
2004-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4912755564ae47bb6c0033da76c6f95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfafb57433f2e9129fd1fd99443eefe2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f782242226dc1f72e5be3f65674f625
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_369e14851097cf26ecfb09c52732b78a |
| publicationDate |
2011-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8017388-B2 |
| titleOfInvention |
Tumour cell lines and uses thereof |
| abstract |
The present invention relates to a cell line selected from the group consisting of (a) a cell line denominated NM-F9 having the DSMZ accession number DSM ACC2606; (b) a cell line denominated NM-D4 having the DSMZ accession number DSM ACC2605; and subclones of (a) or (b). Additionally, the present invention provides a lysate of the cell lines or a molecule or mixture of molecules obtained from these cell lines as well as dendritic cells loaded with said lysate, co-cultivated or fused with cells from the cell lines, or a molecule or mixture of molecules obtained from these cell lines of the present invention. Moreover compositions, preferably pharmaceutical or vaccine compositions are provided which comprise the cell lines, lysate, molecules, mixture of molecules or dendritic cells of the present invention. In another aspect the present invention relates to methods for producing the aforementioned compositions. Furthermore, methods and uses for vaccination against or treatment or prevention of cancers and/or tumourous diseases are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8592165-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9700610-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9494587-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8283161-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9051356-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10280230-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010028947-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010303837-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010158952-A1 |
| priorityDate |
2003-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |